Reliability of PSA circulating cells as markers of metastatic prostate cancer

Author： Cardillo Maria Rosaria   Silverio Franco Di   Gentile Vincenzo  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.64, Iss.7, 2004-10, pp. : 687-690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PSA Decrease with Fulvestrant Acetate in a Hormone-Resistant Metastatic Prostate Cancer Patient

By  

Oncology Research and Treatment, Vol. 33, Iss. 1-2, 2010-01 ,pp. : 57-59

Karger

Access to resources Recommend Favorite

Prevalence of Circulating Tumor Cells in Localized Prostate Cancer

By  

Current Urology, Vol. 7, Iss. 2, 2013-10 ,pp. : 65-69

Karger

Access to resources Recommend Favorite

Analogous detection of circulating tumor cells using the AccuCyte®—CyteFinder® system and ISET system in patients with locally advanced and metastatic prostate cancer

By  

THE PROSTATE, Vol. 78, Iss. 4, 2018-03 ,pp. : 300-307

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metastatic Prostate Cancer in an Asymptomatic Patient with an Initial Prostate-Specific Antigen (PSA) Serum Concentration of 21,380 ng/ml

By  

Oncology Research and Treatment, Vol. 33, Iss. 3, 2010-02 ,pp. : 110-112

Karger

Access to resources Recommend Favorite

Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 11, 2015-08 ,pp. : 1167-1176

John Wiley & Sons Inc

Access to resources Recommend Favorite